AMGN
Amgen Inc.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$438.48
−1.27%Margins
Gross margin
72.7%
EBITDA margin
43.3%
EBIT margin
33.2%
Net margin
22.9%
FCF margin
26.7%
74.8%
Return on equity
9.1%
Return on assets
18.3%
Return on invested capital
0.41x
Asset turnover
$12.5B
Cash from operations
$26
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026